4//SEC Filing
Cytosorbents Corp 4
Accession 0001144204-16-107724
$CTSOCIK 0001175151operating
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:00 PM ET
Size
8.2 KB
Accession
0001144204-16-107724
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-06-07+20,000→ 20,000 totalExercise: $4.69Exp: 2026-06-07→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2016-06-07+2,000→ 2,000 totalExercise: $8.07Exp: 2025-04-08→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]On April 8, 2015, the reporting person was granted an option to purchase 20,000 shares of common stock, which was to vest upon the satisfaction of certain performance criteria for the fiscal year ending December 31, 2015. The Board of Directors of CytoSorbents Corporation determined that 10% of such performance criteria was achieved during 2015, resulting in the vesting of 2,000 shares underlying this option.
- [F2]Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of CytoSorbents Corporation.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175151
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:00 PM ET
- Size
- 8.2 KB